Gilead Sciences has announced that the FDA has approved the single tablet HIV-1 regimen Complera A for use in certain virologically-suppressed adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen.
http://www.pharmpro.com/news/2013/12/fda-approves-gilead%E2%80%99s-once-daily-single-tablet-hiv-1-regimen
http://www.pharmpro.com/news/2013/12/fda-approves-gilead%E2%80%99s-once-daily-single-tablet-hiv-1-regimen
No comments:
Post a Comment